Daily Archives: August 6, 2020

Bombardier Reports Second Quarter 2020 Financial Results, Progress on Near-Term Priorities

Pro-forma(1) liquidity(2) of approximately $3.5 billion, including approximately $1.7 billion of consolidated cash on hand, $738 million of available revolver capacity at Transportation as of June 30, 2020, and up to $1.0 billion of new liquidity from recently announced senior secured credit facility Free cash flow usage(3) and cash flow usage from operating activities better

Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020

GAITHERSBURG, Md., Aug. 06, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its second quarter 2020 financial and operating results following the close of U.S. financial markets on Monday, August 10, 2020. Conference call details are as follows:

Jokowi eyeing leap in tourism through integrated management support

  Jakarta (ANTARA) – Integrated management support will help bring about a leap in Indonesia’s tourism sector, according to President Joko Widodo (Jokowi). “Thus, the country will take a leap in the tourism sector as well as in the management of the tourism ecosystem and its supporters,” President Jokowi stated at a limited meeting at

Papua’s Kurik health center closed after resident contracted COVID-19

Jayapura, Papua (ANTARA) – Kurik Health Center in Kurik Sub-district, Merauke, Papua, terminated services for intensive care unit and inpatient rooms from Aug 6 to Aug 21 after a resident treated there tested positive for novel coronavirus disease (COVID-19). Nine of the health center’s 50 medical workers were also isolated, while the infected resident was

Bio Farma commences phase 3 clinical trial for COVID-19 vaccine

Jakarta (ANTARA) – State-owned vaccine manufacturer Bio Farma has begun the third phase of the clinical trial for a COVID-19 vaccine from China-based biopharmaceutical company Sinovac Biotech on Thursday. “On the occasion of our 130th anniversary today on Thursday (August 6), we will start the clinical trial for development of the COVID-19 vaccine,” Bio Farma